NAV

Cyclic 3',5'-thymidine monophosphate

Identification

Generic Name
Cyclic 3',5'-thymidine monophosphate
DrugBank Accession Number
DB04672
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 304.1932
Monoisotopic: 304.046037292
Chemical Formula
C10H13N2O7P
Synonyms
  • 3',5'-Cyclic dTMP
  • cTMP
  • Cyclic TMP
  • Thymidine cyclophosphate
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
U5'(3')-deoxyribonucleotidase, mitochondrialNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as pyrimidine 2',3'-dideoxyribonucleoside monophosphates. These are pyrimidine nucleotides with monophosphate group linked to the ribose moiety lacking a hydroxyl group at positions 2 and 3.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
Pyrimidine nucleotides
Sub Class
Pyrimidine deoxyribonucleotides
Direct Parent
Pyrimidine 2',3'-dideoxyribonucleoside monophosphates
Alternative Parents
Nucleoside and nucleotide analogues / Pyrimidones / Monoalkyl phosphates / Hydropyrimidines / Vinylogous amides / Dihydrofurans / Heteroaromatic compounds / Ureas / Lactams / Azacyclic compounds
show 6 more
Substituents
Alkyl phosphate / Aromatic heteromonocyclic compound / Azacycle / Dihydrofuran / Heteroaromatic compound / Hydrocarbon derivative / Hydropyrimidine / Lactam / Monoalkyl phosphate / Organic nitrogen compound
show 14 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
furans, nucleoside monophosphate analogue (CHEBI:41735)
Affected organisms
Not Available

Chemical Identifiers

UNII
Q77PE87U4K
CAS number
6453-60-7
InChI Key
XLPGURCDSRIXFL-JGVFFNPUSA-N
InChI
InChI=1S/C10H13N2O7P/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(19-8)5-18-20(15,16)17/h2-4,7-8H,5H2,1H3,(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1
IUPAC Name
{[(2S,5R)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy}phosphonic acid
SMILES
[H][C@]1(COP(O)(O)=O)O[C@]([H])(C=C1)N1C=C(C)C(=O)NC1=O

References

General References
Not Available
PubChem Compound
461278
PubChem Substance
46508608
ChemSpider
405848
ChEMBL
CHEMBL403328
ZINC
ZINC000006521243
PDBe Ligand
D4M
PDB Entries
1z4q / 6uu3 / 6wpf

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility4.64 mg/mLALOGPS
logP-0.98ALOGPS
logP-0.36Chemaxon
logS-1.8ALOGPS
pKa (Strongest Acidic)1.24Chemaxon
pKa (Strongest Basic)-4.2Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area125.4 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity66.19 m3·mol-1Chemaxon
Polarizability25.93 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.5462
Blood Brain Barrier+0.9235
Caco-2 permeable-0.8177
P-glycoprotein substrateNon-substrate0.7562
P-glycoprotein inhibitor INon-inhibitor0.8241
P-glycoprotein inhibitor IINon-inhibitor0.9526
Renal organic cation transporterNon-inhibitor0.935
CYP450 2C9 substrateNon-substrate0.6233
CYP450 2D6 substrateNon-substrate0.8545
CYP450 3A4 substrateNon-substrate0.546
CYP450 1A2 substrateNon-inhibitor0.8677
CYP450 2C9 inhibitorNon-inhibitor0.8405
CYP450 2D6 inhibitorNon-inhibitor0.8923
CYP450 2C19 inhibitorNon-inhibitor0.8186
CYP450 3A4 inhibitorNon-inhibitor0.889
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8907
Ames testNon AMES toxic0.7827
CarcinogenicityNon-carcinogens0.8456
BiodegradationNot ready biodegradable0.7279
Rat acute toxicity2.3106 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9583
hERG inhibition (predictor II)Non-inhibitor0.8643
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-002b-9710000000-9ad52aa44c70136b0949
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-2269000000-dc4031b7977cbc1c499c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-4009000000-edac3e150356a483f67f
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9031000000-7053a22fe0233c973ad7
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-7890000000-62432fdff1b6fd6682af
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9010000000-5847e153707e9b8c1254
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-4920000000-9a7ce68c7c4833178074
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-173.5988493
predicted
DarkChem Lite v0.1.0
[M-H]-164.49834
predicted
DeepCCS 1.0 (2019)
[M+H]+175.0553493
predicted
DarkChem Lite v0.1.0
[M+H]+166.85649
predicted
DeepCCS 1.0 (2019)
[M+Na]+175.9451493
predicted
DarkChem Lite v0.1.0
[M+Na]+173.36656
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. 5'(3')-deoxyribonucleotidase, mitochondrial
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Nucleotide binding
Specific Function
Dephosphorylates specifically the 5' and 2'(3')-phosphates of uracil and thymine deoxyribonucleotides, and so protects mitochondrial DNA replication from excess dTTP. Has only marginal activity tow...
Gene Name
NT5M
Uniprot ID
Q9NPB1
Uniprot Name
5'(3')-deoxyribonucleotidase, mitochondrial
Molecular Weight
25861.505 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52